The Effect of Spinal Cord Stimulators on Restless Leg Syndrome
University of Alabama at Birmingham · NCT07179406
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- August 4, 2025
- Record last updated
- June 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study aims to evaluate neurophysiological responses and symptom changes in individuals with Restless Legs Syndrome (RLS) and/or chronic pain. Participants will undergo standard clinical assessments including EEG, EMG, h-reflex, SSEP, ERP, and TMS under varying SCS conditions.The study involves 4 arms. Arm 1 are individuals diagnosed with RLS and Healthy Controls. Arm 2 are individuals diagnosed with RLS and have an existing SCS. Arm 3 are individuals diagnosed with RLS and scheduled to receive a SCS. Arm 4 are individuals with chronic pain and have a SCS, but no diagnosis of RLS.
Being studied: H-Reflex; Somatosensory evoked potential (SSEP); Vibratory Electrophysiological Response Potential (ERP); Transcranial Magnetic Stimulation (TMS); Spinal Cord Stimulator (SCS) manipulation
Conditions: Restless Leg Syndrome (RLS); Spinal Cord Stimulation (SCS)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Has Restless Leg Syndrome
- No major changes in RLS medications in past 4 weeks
- Willing and able to comply with study protocol
- Healthy Controls - No RLS diagnosis
- Ability to provide informed consent
Exclusion Criteria
- Any mental or physical limitation that would prevent completing any of the studies
- Currently using another device to treat RLS
- Unable or unwilling to comply with study protocols
- Other medical condition that would put the subject at risk as determined by the investigator
- Pregnant, breastfeeding, or trying to become pregnant
- Currently participating or planning to participate in any other investigational clinical evaluation during the study period that may, in the opinion of the investigator, affect RLS
- One or more of the following diseases: spinal cord injury, severe peripheral neuropathy or radiculopathy, severe psychiatric or cognitive disorder that may interfere with participation of the study, history of drug or alcohol abuse within the past year, epilepsy or seizure disorder, current active or chronic infection other than the common cold, malignancy within the past 5 years (not including basal cell or squamous cell skin cancer), severe movement disorder (i.e. Parkinson's disease), deep vein thrombosis, or multiple sclerosis.
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35233
Site contact: Marshall Holland, MD · 2059343411 · mtholland@uabmc.edu
Study contacts (from the official record)
- Marshall Holland, MD · 2059343411 · mtholland@uabmc.edu
Similar studies in Alabama
All sleep studies in Alabama →- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Cullman, AL + 32 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Eli Lilly and Company
- Location
- Cullman, AL + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
Jazz Pharmaceuticals
- Location
- Birmingham, AL + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Alkermes, Inc.
- Location
- Cullman, AL + 21 other US sites
- Eligibility basics
- Ages 18–70